Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02489903
Title RRx-001 in Small, Non-small Cell Lung Cancer, and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors EpicentRx, Inc.
Indications

lung small cell carcinoma

lung non-small cell carcinoma

neuroendocrine tumor

Therapies

Etoposide

RRx-001

Carboplatin

Cisplatin

Nab-paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.